493 related articles for article (PubMed ID: 24731445)
41. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
42. Angiotensin II induces calcium/calcineurin signaling and podocyte injury by downregulating microRNA-30 family members.
Zhao Y; Wu J; Zhang M; Zhou M; Xu F; Zhu X; Zhou X; Lang Y; Yang F; Yun S; Shi S; Liu Z
J Mol Med (Berl); 2017 Aug; 95(8):887-898. PubMed ID: 28540409
[TBL] [Abstract][Full Text] [Related]
43. Losartan treating podocyte injury induced by Ang II via downregulation of TRPC6 in podocytes.
Chi-Xianggeng ; Hu-Bo ; Yu SY; Yin-Lianghong ; Meng-Yu ; Wang-Boxun ; Yang-Jinsheng ; Lin-Jiahui ; Huang-Dexu ; Chen-Lanlan
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1118-24. PubMed ID: 25795457
[TBL] [Abstract][Full Text] [Related]
44. Sex dimorphism in ANGII-mediated crosstalk between ACE2 and ACE in diabetic nephropathy.
Clotet-Freixas S; Soler MJ; Palau V; Anguiano L; Gimeno J; Konvalinka A; Pascual J; Riera M
Lab Invest; 2018 Sep; 98(9):1237-1249. PubMed ID: 29884907
[TBL] [Abstract][Full Text] [Related]
45. Over-expressing transient receptor potential cation channel 6 in podocytes induces cytoskeleton rearrangement through increases of intracellular Ca2+ and RhoA activation.
Jiang L; Ding J; Tsai H; Li L; Feng Q; Miao J; Fan Q
Exp Biol Med (Maywood); 2011 Feb; 236(2):184-93. PubMed ID: 21321315
[TBL] [Abstract][Full Text] [Related]
46. Diabetic conditions downregulate the expression of CD2AP in podocytes via PI3-K/Akt signalling.
Ha TS; Hong EJ; Han GD
Diabetes Metab Res Rev; 2015 Jan; 31(1):50-60. PubMed ID: 24846128
[TBL] [Abstract][Full Text] [Related]
47. The mTORC2/Akt/NFκB Pathway-Mediated Activation of TRPC6 Participates in Adriamycin-Induced Podocyte Apoptosis.
Zhang HT; Wang WW; Ren LH; Zhao XX; Wang ZH; Zhuang DL; Bai YN
Cell Physiol Biochem; 2016; 40(5):1079-1093. PubMed ID: 27960162
[TBL] [Abstract][Full Text] [Related]
48. Sensitizing the Slit Diaphragm with TRPC6 ion channels.
Möller CC; Flesche J; Reiser J
J Am Soc Nephrol; 2009 May; 20(5):950-3. PubMed ID: 18784209
[TBL] [Abstract][Full Text] [Related]
49. Knockout of TRPC6 promotes insulin resistance and exacerbates glomerular injury in Akita mice.
Wang L; Chang JH; Buckley AF; Spurney RF
Kidney Int; 2019 Feb; 95(2):321-332. PubMed ID: 30665571
[TBL] [Abstract][Full Text] [Related]
50. The effects of siRNA-silenced TRPC6 on podocyte autophagy and apoptosis induced by AngII.
Shengyou Y; Li Y
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1266-73. PubMed ID: 25143325
[TBL] [Abstract][Full Text] [Related]
51. Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice.
Zhao S; Ghosh A; Lo CS; Chenier I; Scholey JW; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
Endocrinology; 2018 Feb; 159(2):836-852. PubMed ID: 29211853
[TBL] [Abstract][Full Text] [Related]
52. Angiotensin II activation of TRPC6 channels in rat podocytes requires generation of reactive oxygen species.
Anderson M; Roshanravan H; Khine J; Dryer SE
J Cell Physiol; 2014 Apr; 229(4):434-42. PubMed ID: 24037962
[TBL] [Abstract][Full Text] [Related]
53. Klotho Ameliorates Podocyte Injury through Targeting TRPC6 Channel in Diabetic Nephropathy.
Yao X; Guo H; Sun M; Meng S; Zhu B; Fang J; Huang J; Wang H; Xing L
J Diabetes Res; 2022; 2022():1329380. PubMed ID: 35480629
[TBL] [Abstract][Full Text] [Related]
54. eNOS deficiency predisposes podocytes to injury in diabetes.
Yuen DA; Stead BE; Zhang Y; White KE; Kabir MG; Thai K; Advani SL; Connelly KA; Takano T; Zhu L; Cox AJ; Kelly DJ; Gibson IW; Takahashi T; Harris RC; Advani A
J Am Soc Nephrol; 2012 Nov; 23(11):1810-23. PubMed ID: 22997257
[TBL] [Abstract][Full Text] [Related]
55. Ezrin is down-regulated in diabetic kidney glomeruli and regulates actin reorganization and glucose uptake via GLUT1 in cultured podocytes.
Wasik AA; Koskelainen S; Hyvönen ME; Musante L; Lehtonen E; Koskenniemi K; Tienari J; Vaheri A; Kerjaschki D; Szalay C; Révész C; Varmanen P; Nyman TA; Hamar P; Holthöfer H; Lehtonen S
Am J Pathol; 2014 Jun; 184(6):1727-39. PubMed ID: 24726496
[TBL] [Abstract][Full Text] [Related]
56. Local kallikrein-kinin system is involved in podocyte apoptosis under diabetic conditions.
Kwak SJ; Paeng J; Kim DH; Lee SH; Nam BY; Kang HY; Li JJ; Jung DS; Han SH; Ryu DR; Park JT; Chang TI; Yoo TH; Han DS; Kang SW
Apoptosis; 2011 May; 16(5):478-90. PubMed ID: 21373934
[TBL] [Abstract][Full Text] [Related]
57. Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli.
Ilatovskaya DV; Palygin O; Chubinskiy-Nadezhdin V; Negulyaev YA; Ma R; Birnbaumer L; Staruschenko A
Kidney Int; 2014 Sep; 86(3):506-14. PubMed ID: 24646854
[TBL] [Abstract][Full Text] [Related]
58. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
59. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
60. Gene expression patterns in glucose-stimulated podocytes.
Han SH; Yang S; Jung DS; Li JJ; Kim JJ; Kwak SJ; Kim DK; Moon SJ; Lee JE; Han DS; Kang SW
Biochem Biophys Res Commun; 2008 Jun; 370(3):514-8. PubMed ID: 18395008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
